Nervgen Pharma NGEN
NASDAQ NGEN
$1.42 -0.08 (-5.33%)
At close: Oct 22, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Total Debt (2024 - 2025)

Updated

Nervgen Pharma's Total Debt was $6,001 in the quarter ended Dec 31, 2025, down 91.4% from $69,605 a year earlier.

Analysis

Nervgen Pharma (NGEN) Total Debt (2024 - 2025) Analysis & Trends

As of Dec 31, 2025, Total Debt at Nervgen Pharma came in at $5,990, down 91.6% from the prior year.

  • In earlier years, Total Debt was $71,020 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 44.65 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 70.82 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 32.35 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 26.25 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 63.19 Bn
10 Nervgen Pharma 113.10 Mn 11.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6,111.12
Dec 31, 2024 67,759.83
API Access

Nervgen Pharma Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=NGEN&period=max&api_key=YOUR_API_KEY